Identification and treatment of (sub)clinical transcatheter valve thrombosis

Sponsored by Daiichi Sankyo, Inc. and Pie Medical Imaging
Coronary Interventions
Other coronary interventions
Drugs and Devices Synergy
Daiichi Sankyo, Inc.
Room 253

Discussants: Christian Hengstenberg, Rutger-Jan Nuis

Watch this session if you want

  • To learn how to determine leaflet thickening and leaflet mobility by MSCT
  • To get an update on antithrombotic treatment strategies of HALT/RLM
  • To understand potential clinical implications of HALT and RLM (HAM)
Session objectives

Nicolas Van Mieghem

A practical guide to CT diagnosis of HALT/RLM

Hasan Jilhaihawi

Discussion and audience interaction
Why should we take HALT/RLM seriously?

Joelle Kefer

Discussion and audience interaction
How to approach HALT/HAM - Impact of pharmacotherapy

Christian Hengstenberg

Discussion and audience interaction
Session evaluation and key learnings

Nicolas Van Mieghem